ATE113940T1 - Aminobenzolsulfonsäurederivate. - Google Patents

Aminobenzolsulfonsäurederivate.

Info

Publication number
ATE113940T1
ATE113940T1 AT90400795T AT90400795T ATE113940T1 AT E113940 T1 ATE113940 T1 AT E113940T1 AT 90400795 T AT90400795 T AT 90400795T AT 90400795 T AT90400795 T AT 90400795T AT E113940 T1 ATE113940 T1 AT E113940T1
Authority
AT
Austria
Prior art keywords
group
sulfonic acid
acid derivatives
aminobenzene sulfonic
alkyl group
Prior art date
Application number
AT90400795T
Other languages
English (en)
Inventor
Hiromi Okushima
Akihiro Narimatsu
Makio Kobayashi
Naoya Satoh
Miyuki Morita
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Application granted granted Critical
Publication of ATE113940T1 publication Critical patent/ATE113940T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90400795T 1989-03-27 1990-03-22 Aminobenzolsulfonsäurederivate. ATE113940T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7468489 1989-03-27
JP2064811A JPH0686438B2 (ja) 1989-03-27 1990-03-15 アミノベンゼンスルホン酸誘導体

Publications (1)

Publication Number Publication Date
ATE113940T1 true ATE113940T1 (de) 1994-11-15

Family

ID=26405909

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400795T ATE113940T1 (de) 1989-03-27 1990-03-22 Aminobenzolsulfonsäurederivate.

Country Status (7)

Country Link
EP (1) EP0390654B1 (de)
JP (1) JPH0686438B2 (de)
AT (1) ATE113940T1 (de)
CA (1) CA2013037C (de)
DE (1) DE69013959T2 (de)
DK (1) DK0390654T3 (de)
ES (1) ES2063300T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192731C (en) 1995-12-15 2005-09-27 Chika Yamazaki Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
US5965560A (en) * 1996-04-30 1999-10-12 Warner-Lambert Company Substituted piperazines and piperidines as central nervous system agents
US5859246A (en) * 1997-01-30 1999-01-12 Neurogen Corporation 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
CN1109677C (zh) * 1997-06-13 2003-05-28 三菱化学株式会社 氨基苯磺酸衍生物的单水合物及其制备方法
DE69941897D1 (de) * 1998-02-12 2010-02-25 Mitsubishi Chem Corp Arzneimittel für nicht-cardiogene diastolische dysfunktion
US6407113B1 (en) 1998-02-12 2002-06-18 Mitsubishi Chemical Corporation Medicament for treatment of diastolic dysfunction
AU2398001A (en) * 1999-12-21 2001-07-03 Mitsubishi Pharma Corporation Remedies and/or preventives for nervous system disorders
WO2002004433A2 (en) 2000-07-06 2002-01-17 Neurogen Corporation Melanin concentrating hormone receptor ligands
US20050124632A1 (en) * 2001-03-13 2005-06-09 Yoshimi Kitada Remedies and/or preventives for diabetic ischemic heart diseases
BR0209932A (pt) 2001-05-22 2004-10-13 Neurogen Corp Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
EP1409080A1 (de) * 2001-07-25 2004-04-21 Mitsubishi Pharma Corporation Arzneimittel zur hemmung des natrium/calcium-austauschsystems
US20050004139A1 (en) * 2001-07-30 2005-01-06 Takeshi Inamori Pharmaceutical preparations containing aminobenzene-sulfonic acid derivatives as the active ingredient
US20060167013A1 (en) * 2002-08-30 2006-07-27 Naoya Satou Inhibitors for excessive accumulation of sodium ion in cells
WO2004022545A1 (ja) * 2002-09-06 2004-03-18 Mitsubishi Pharma Corporation 移植臓器保護剤
WO2004069275A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation 眼科用剤
EP1723955A4 (de) * 2004-03-05 2009-12-23 Mitsubishi Tanabe Pharma Corp Medikament zur prävention und/oder behandlung von ischämischer kreislauferkrankung
WO2005110982A2 (en) 2004-04-07 2005-11-24 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
EP2050741A4 (de) * 2006-07-21 2009-10-28 Mitsubishi Tanabe Pharma Corp Kristalliner polymorphismus von 5-methyl-2-(piperazin-1-yl)benzolsulfonsäure
WO2008010567A1 (fr) * 2006-07-21 2008-01-24 Mitsubishi Tanabe Pharma Corporation Sel ou solvate d'acide 5-méthyl-2-(pipérazin-1-yl)benzènesulfonique
JPWO2008032814A1 (ja) * 2006-09-14 2010-01-28 田辺三菱製薬株式会社 含アスピリン医薬
WO2011134169A1 (en) 2010-04-30 2011-11-03 Beijing Institute Of Technology Wide angle and high resolution tiled head-mounted display device
WO2026004998A1 (ja) * 2024-06-28 2026-01-02 田辺三菱製薬株式会社 角化症用医薬組成物およびその用途
TW202610627A (zh) * 2024-06-28 2026-03-16 日商田邊三菱製藥股份有限公司 家族性良性慢性天疱瘡用醫藥組成物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1104514B (de) * 1955-06-29 1961-04-13 Parke Davis & Co Verfahren zur Herstellung von blutdrucksenkend wirkenden 1-Mercaptophenyl-4-piperazino-alkoholen
DE2040279A1 (de) * 1970-08-13 1972-02-17 Hoechst Ag Verfahren zur Herstellung basisch substituierter Benzolsulfonamide
DE2111811A1 (de) * 1971-03-12 1972-09-14 Hoechst Ag Basisch substituierte Benzolsulfonylformamidine und Verfahren zu ihrer Herstellung
DE3715763A1 (de) * 1987-05-12 1988-11-24 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
DE69013959D1 (de) 1994-12-15
DK0390654T3 (da) 1995-04-03
EP0390654B1 (de) 1994-11-09
JPH0686438B2 (ja) 1994-11-02
CA2013037C (en) 1999-12-07
CA2013037A1 (en) 1990-09-27
ES2063300T3 (es) 1995-01-01
JPH037263A (ja) 1991-01-14
DE69013959T2 (de) 1995-03-16
EP0390654A1 (de) 1990-10-03

Similar Documents

Publication Publication Date Title
DK0390654T3 (da) Aminobenzensulfonsyrederivater
AU657106B2 (en) Preparation and use of N-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents
DK0850926T3 (da) Difluorprostaglandinderivater og deres anvendelse
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
PT918776E (pt) Sintese total de acilfulvenos antitumorais
MX9100227A (es) Derivados de cefalosporina y procedimiento para su preparacion.
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
TW352383B (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them
AU6158486A (en) Dihydro pyridine derivatives
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
MX11866A (es) Nuevas cicloalquilamidas y procedimiento para su preparacion.
AU623500B2 (en) Carboxylimino benzothiazole derivatives
DK0812835T3 (da) Optisk aktive thiazolidinonderivater
AU610913B2 (en) 2'-deoxy-5-fluorouridine derivatives
ATE112769T1 (de) Benzoxazepinderivate.
ES2032214T3 (es) Un procedimiento para la preparacion de un derivado de ergolina.
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
FI900973A0 (fi) Menetelmä valmistaa 2,3,4,5-tetrahydro-5-metyyli-1-/(5-metyyli-1H-imidatsol-4-yyli)-metyyli)/-1H-pyrido/4,3-b/-indol-1-onia
BR9305092A (pt) Processo para a preparação de derivados de 5-pirazolmercáptan, composto ditiocarbazato de etilideno, processo para a preparação de derivados do mesmo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EELA Cancelled due to lapse of time